Research Field
연구분야
연구분야
•home > 연구분야 > 발표논문
발표논문
Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice.
작성자
pmrc
작성일
2019-03-21 15:36
조회
370
Choi, Y., Lee, S., Kim, K., Kim, S. H., Chung, Y. J., & Lee, C. (2018). Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice. Experimental & molecular medicine, 50(8), 99.
DOI: 10.1038/s12276-018-0115-0
Abstract
Cancer immunotherapy is a promising way to eliminate tumor cells by using the patient's own immune system. Selecting the appropriate animal models to develop or validate preclinical immunotherapeutic trials is now an important aspect of many cancer research programs. Here we discuss the advantages and limitations of using genetically engineered immunodeficient mouse models, patient-derived xenografts (PDXs), and humanized mouse models for developing and testing immunotherapeutic strategies.
DOI: 10.1038/s12276-018-0115-0
Abstract
Cancer immunotherapy is a promising way to eliminate tumor cells by using the patient's own immune system. Selecting the appropriate animal models to develop or validate preclinical immunotherapeutic trials is now an important aspect of many cancer research programs. Here we discuss the advantages and limitations of using genetically engineered immunodeficient mouse models, patient-derived xenografts (PDXs), and humanized mouse models for developing and testing immunotherapeutic strategies.